We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Spark Biopharma Stock

Invest in or calculate the value of your shares in Spark Biopharma or other pre-IPO companies through EquityZen's platform.

Get Started

Spark Biopharma Stock (SPBI)

Spark Biopharma is a biotechnology company

About Spark Biopharma Stock

Founded

2016

Industries

Software, Artificial Intelligence, Data and Analytics

SPARK BioPharma Co., Ltd. was established in Seoul National University in January 2016 based on the unique drug molecule diversity technology, the image-based screening technology using the unique fluorescent skeleton probe, and the target protein identification technology in the initial drug development stage. We are currently exploring and developing new drug candidates using these three core technologies, and we will continue to accelerate the development of new drugs and increase the success rate through strategic cooperation research with domestic and overseas research institutes and pharmaceutical institutions. '

Spark Biopharma Press Mentions

Stay in the know about the latest news on Spark Biopharma

Spark Biopharma Management

Leadership team at Spark Biopharma

Founder and CEO

Seung Bum Park

Locked Features

Join now and verify your accreditation status to gain access to:

  • Spark Biopharma Current Valuation
  • Spark Biopharma Stock Price
  • Spark Biopharma Management
  • Available deals in Spark Biopharma and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Spark Biopharma Cap Table and Funding History by Share Class and Liquidity Preferences
    • Spark Biopharma Revenue and Financials
    • Spark Biopharma Highlights
    • Spark Biopharma Business Model
    • Spark Biopharma Risk Factors
  • Spark Biopharma Research Report from SACRA Research
Join Now

Trading Spark Biopharma Stock

How to invest in Spark Biopharma stock?

Accredited investors can buy pre-IPO stock in companies like Spark Biopharma through EquityZen funds. These investments are made available by existing Spark Biopharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Spark Biopharma stock?

Shareholders can sell their Spark Biopharma stock through EquityZen's private company marketplace. EquityZen's network includes over 350K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 45K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."